Spotlighting the most promising biotechnology companies in Israel.

Although it is a smaller country, Israel’s biotechnology sector is flourishing. According to Ernst & Young, BioIsrael has recently experienced a boost of venture capital placing it among the ranks of larger biotech companies. With more capital, IsraelBio has been able to increase the number of products within Phase III development. IsraelBio also boasts a large number of students and graduates in life sciences, showing promise for future growth and development.

Sponsor
Pfizer


Hotbed News
J.P. Morgan Gives Some Love to 3 Battered Specialty Pharma Stocks Tuesday, June 28, 2016
3 Tips that Could Help Biotech Investors Make Big Bucks Wednesday, June 08, 2016
Inside the Biotech Employer's Head: Job Interview Questions That You Should Be Ready to Answer Thursday, June 16, 2016
Teva (TEVA) Divests Eight Products to Dr. Reddy's Laboratories Ltd. (RDY)'s for $350 Million Monday, June 13, 2016
Teva (TEVA) Announces FDA Acceptance Of New Drug Applications For Fluticasone Propionate/Salmeterol And Fluticasone Propionate RespiClick Inhalers Tuesday, June 28, 2016
Kitov (KTOV)'s Lead Drug KIT-302 Achieves Manufacturing Milestone Ahead Of Planned NDA Filing With U.S. FDA Tuesday, June 28, 2016
Future Fit: What It Takes to Make New Graduates Employable Thursday, June 23, 2016
Can-Fite BioPharma (CFBI) Reports New Data Showing Its Psoriasis Drug May Offer Efficacy Similar To Industry Leading Biologics Without Harmful Side Effects Thursday, June 16, 2016
Teva (TEVA) Suspends Marketing for ZECUITY in the U.S. Monday, June 13, 2016
BioLineRx Announces Regulatory Submissions For Phase 2a Trial Of BL-8040 In Combination With KEYTRUDA (Pembrolizumab) For Treatment Of Pancreatic Cancer Tuesday, June 28, 2016
12345678910